Business
Cannabics Pharmaceuticals Reveals Different Extraction Methods Result in Differential Necrotic Effects of Cannabis on Gastrointestinal Cancer Cells
Cannabics Pharmaceuticals Reveals Different Extraction Methods Result in Differential Necrotic Effects of Cannabis on Gastrointestinal Cancer Cells.
About this update from Cnbx Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nCannabics Pharmaceuticals Reveals Different Extraction Methods Result in Differential Necrotic Effects of Cannabis on Gastrointestinal Cancer Cells\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nCannabics Pharmaceuticals Reveals Different Extraction Methods Result in Differential Necrotic Effects of Cannabis on Gastrointestinal Cancer Cells\nPR Newswire\nTEL AVIV, Israel and BETHESDA, Maryland, March 2, 2020\n\n\n\n\n \n \n \n TEL AVIV, Israel and BETHESDA, Maryland, March 2, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, released an update today regarding its pre-clinical studies held at the company's High Throughput Screening (HTS) facility in Israel.\n\n \n \n \n \n \n \n\n \n\nThe preliminary results indicate that different extraction methods result in varied antitumor properties of cannabis BRM (Botanical Raw Material) exhibited in necrotic effects on gastrointestinal cancer cells.\nEdible products in the cannabis industry are infused with cannabis resin extracted by three main methods: CO2, ethanol and pressure. These methods have advantages and disadvantages however their effect on the medicinal properties of cannabis for cancer patients were never clinically tested.\nThe current study indicated that heat and pressure extracts a more potent fraction of the plant than CO2 and ethanol in most of the cannabis strains tested. The study will further examine the chemical bases for this differentiation while its implications are clear. The development of medicine based on botanical material is confound to various parameters such as genetics, growth conditions and according to this study – extraction methods. The company also examines the effects of post extraction manipulation such as decarboxylation, winterization and formulation on the invitro toxic effects.\nAbout Cannabics Pharmaceuticals\nCannabics Pharmaceuticals Inc. (OTCQB: CNBX) is a U.S public company that is developing a platform that leverages novel drug-screening tools to create canna...